Oral antiviral drug reduces death risk by 50% in COVID-19 patient
HEALTH

Oral antiviral drug reduces death risk by 50% in COVID-19 patient

Oral antiviral drug reduces death risk by 50% in COVID-19 patient

File photo

-/-

No deaths reported through day 29 in patients who received Molnupiravir drug, study shows

  • News Service 01 OCTOBER 2021, 03:04AA
  • antiviral drug
  • COVID-19
  • patient
  • Merck and Ridgeback Biotherapeutics
SON DAKİKA

#title#